We look back on last year’s Canadian intellectual property highlights and most interesting cases, including a highly-anticipated copyright fair use ruling, clarification of the double patenting test, CETA legislation and the introduction of patent and trademark agent privilege
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application